🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

RBC raises M&T Bank stock target, sees strong credit performance

EditorNatashya Angelica
Published 18/10/2024, 13:24
MTB
-

On Friday, RBC Capital Markets updated its outlook on shares of M&T Bank Corporation (NYSE:MTB), increasing the price target to $208 from the previous $190 while maintaining an Outperform rating on the stock. The firm highlighted the bank's robust business model and prudent credit management as key factors for the positive stance.

The RBC Capital analyst lauded M&T Bank's approach to banking, which is characterized by a straightforward and reliable strategy, often described as "meat and potatoes." This philosophy is a legacy of the bank's former CEO, Bob Wilmers, and is being continued by the current CEO, Rene Jones.

According to the analyst, M&T Bank's consistent performance in credit through various economic cycles sets it apart and is becoming a focal point for investor discussions.

The analyst emphasized M&T Bank's track record of avoiding credit pitfalls as a critical element in generating long-term value for shareholders. The bank achieves this by maintaining stringent underwriting standards, which has been a cornerstone of its business practices.

Furthermore, M&T Bank's adept capital management was noted as a contributing factor to the enhancement of shareholder returns over the years. The bank's strategic financial decisions have been recognized as a strength that supports its overall solid performance in the banking sector.

The updated price target reflects confidence in M&T Bank's ability to maintain its strong credit performance and continue providing value to its shareholders. The Outperform rating suggests that RBC Capital Markets expects the bank's stock to do better than the broader market in the foreseeable future.

In other recent news, M&T Bank has reported a 10% increase in Q3 net income, amounting to $721 million. This rise was paralleled by an increase in diluted GAAP earnings per share, which reached $4.02. The bank's performance was marked by improved capital ratios, loan growth, and a positive outlook for the remainder of the year.

M&T Bank's CET1 ratio improved to 11.54%, and its average loans grew to $134.8 billion. The bank also saw non-interest income reaching $606 million. For the full year, the bank expects taxable equivalent net interest income to be at least $1.73 billion.

M&T Bank's future projections include a fourth-quarter taxable equivalent net interest income of at least $1.73 billion and loan growth reaching approximately $136 billion. The bank also anticipates total deposits to reach at least $160 billion.

Moreover, non-interest income for the fourth quarter is estimated at $600 million, with expenses predicted to be around $1.32 billion. These are recent developments that investors may find noteworthy.

InvestingPro Insights

Recent data from InvestingPro aligns with RBC Capital Markets' positive outlook on M&T Bank Corporation (NYSE:MTB). The bank's stock has shown remarkable strength, with a 69.98% total return over the past year and a 45.19% return in the last six months. This performance supports the analyst's confidence in M&T Bank's business model and strategy.

InvestingPro Tips highlight M&T Bank's commitment to shareholder value, noting that the company has raised its dividend for 7 consecutive years and has maintained dividend payments for an impressive 46 consecutive years. This aligns with the analyst's praise for M&T Bank's capital management and its contribution to enhancing shareholder returns.

The bank's P/E ratio of 14.01 suggests that the stock may still be reasonably valued despite its recent strong performance. Moreover, M&T Bank's revenue for the last twelve months stands at $8.499 billion, with an operating income margin of 40.7%, indicating a robust financial position.

For investors seeking more comprehensive analysis, InvestingPro offers 11 additional tips for M&T Bank, providing deeper insights into the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.